Al-Ola Abdallah, Hematologic Oncologist at the University of Kansas Medical Center and member of the US Myeloma Innovations Research Collaborative (USMIRC), shared on X:
“Myeloma Poll? 65-year-old with MM diagnosed 8 years ago – RVD – ASCT – maintenance ×3 years – sCR. was on surveillance.
Now with low-level biochemical recurrence:
- BMBx: 5% monoclonal PCs
- PET/CT: negative
- Involved FLC: 8 mg/dL
- M-protein: 0.3 g/dL
Your next step?”
You can also read: Overwhelming Global Response to World Brachytherapy Awareness Day – ESTRO
